Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 5, 2012, Pages 405-410

  Hashimoto, Yasuhiko ^a,b   Uno, Junji ^d   Miwa, Takaichi ^e   Kurihara, Masaaki ^f   Tanifuji, Hiroaki ^g   Tensho, Masami ^c  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b Sawa Hospital   (Japan)

^c Hokuto Clinic Hospital   (Japan)

^d Okehazama Hospital Fujita Kokoro Care Center   (Japan)

^e Yuge Hospital   (Japan)

^f Kusatsu Hospital   (Japan)

^g Kasamatsu Hospital   (Japan)

Author keywords

non adherence; polypharmacy; schizophrenia; side effects; subjective opinions

Indexed keywords

ADULT; AKATHISIA; ARTICLE; BLURRED VISION; CONSTIPATION; FEMALE; HEALTH SURVEY; HUMAN; HUNGER; JAPAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT COMPLIANCE; POLYPHARMACY; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; SALIVATION; SCHIZOPHRENIA; SEDATION; SEXUAL DYSFUNCTION; SLURRED SPEECH; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTPATIENTS; POLYPHARMACY; QUESTIONNAIRES; SCHIZOPHRENIA; WEIGHT GAIN; XEROSTOMIA;

EID: 84864396515     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2012.02376.x     Document Type: Article

References (25)

1. Wyatt RJ,. Neuroleptics and natural course of schizophrenia. Schizophr. Bull. 1991; 17: 325-351.
2. Marder SR,. Facilitating compliance with antipsychotic medication. J. Clin. Psychiatry 1998; 59 (Suppl. 3): 21-25. (Pubitemid 28196366)
3. Moore A, Sellwood W, Stirling J,. Compliance and psychological reactance in schizophrenia. Br. J. Clin. Psychol. 2000; 39 (Pt 3): 287-295.
4. Fleischhacker WW, Oehl MA, Hummer M,. Factors influencing compliance in schizophrenia patients. J. Clin. Psychiatry 2003; 64 (Suppl. 16): 10-13. (Pubitemid 37523322)
5. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV,. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J. Clin. Psychiatry 2002; 63: 892-909. (Pubitemid 35231730)
6. Cooper C, Bebbington P, King M, et al,. Why people do not take their psychotropic drugs as prescribed: Results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatry Scand. 2007; 116: 47-53. (Pubitemid 46889774)
7. Kuroda N, Sun S, Lin CK, et al,. Attitude toward taking medication among outpatients with schizophrenia: Cross-national comparison between Tokyo and Beijing. Environ. Health Pren. Med. 2008; 13: 288-295.
8. Awad AG, Voruganti LN, Heslegrave RJ, Hogan TP,. Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome. Int. Clin. Psychopharmacol. 1996; 11: 55-59. (Pubitemid 26194502)
9. Slingsby BT,. Decision-making models in Japanese psychiatry: Transition from passive to active patterns. Soc. Sci. Med. 2004; 59: 83-91. (Pubitemid 38490348)
10. Rettenbacher MA, Hofer A, Eder U, et al,. Compliance in schizophrenia: Psychopathology, side effects, and patients' attitude toward the illness and medication. J. Clin. Psychiatry 2004; 65: 1211-1218.
11. Vauth R, Loschmann C, Rusch N, Corrigan PW,. Understanding adherence to neuroleptic treatment in schizophrenia. Psychiatry Res. 2004; 126: 43-49. (Pubitemid 38479794)
12. Weiss KA, Smith TE, Hull JW, Piper AC, Huppert JD,. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorder. Schizophr. Bull. 2002; 28: 341-349. (Pubitemid 35462249)
13. Giner J, Canas F, Olivares JM, et al,. Treatment adherence in schizophrenia: A comparison between patient's, relative's and psychiatrist's opinions. Actas Esp. Psiquiatría 2006; 34: 386-392.
14. Istvan B, Agnes M,. Assessment of therapeutic adherence using questionnaires in patients with schizophrenia. Psychiatr. Hung. 2006; 21: 430-436.
15. Fleischhacker WW, Meise U, Gunther V, Kurz M,. Compliance with antipsychotic drug treatment: Influence of side effects. Acta Psychiatr. Scand. Suppl. 1994; 382: 11-15. (Pubitemid 24199707)
16. The Expert Consensus Guideline Series: Adherence Problems in Patients with Serious and Persistent Mental Illness. J. Clin. Psychiary 2009; 70 (Suppl. 4): 5-46.
17. Hoit RI, Peveler RC,. Antipsychotics and hyperprolactinaemia: Mechanism, consequences and management. Clin. Endocrinol. (Oxf) 2011; 74: 141-147.
18. Luecht S, Corves C, Arbter D, Engel RR, Li C, Davis JM,. Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet 2009; 373: 31-41.
19. Poyurosky M,. Acute antipsychotic-induced akathisia revisited. Br. J. Psychiatry 2010; 169: 89-91.
20. Hida H, Faber M, Alberto-Gondouin MC, Jalaguier E,. Analysis of prescriptions for psychotropic drugs in a psychiatric hospital. Therapie 1997; 52: 573-578. (Pubitemid 28090166)
21. Procyshyn RM, Kennedy NB, Tse G, Thompson B,. Antipsychotic polypharmacy: A survey of discharge prescriptions from a tertiary care psychiatric institution. Can. J. Psychiatry 2001; 46: 334-339. (Pubitemid 32531565)
22. Sim K, Su A, Fujii S, et al,. Antipsychotic polypharmacy in patients with schizophrenia: A multicentre comparative study in East Asia. Br. J. Clin. Pharmacol. 2004; 58: 178-183. (Pubitemid 39043998)
23. Fujii A, Yasui-Furukori N, Sugawara N, et al,. Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog. Neuropsychopharmacolgy Biol. Psychiatry 2010; 34: 288-293.
24. Montgomery J, Winterbottom E, Jessani M, et al,. Prevalence hyperprolactinemia in schizophrenia: Association with typical and atypical antipsychotic treatment. J. Clin. Psychiatry 2004; 65: 1491-1498.
25. Shiloh R, Zemishlany Z, Aizenberg D, et al,. Sulpiride augmentation in people with schizophrenia partially responsive clozapine: A double-blind, placebo-controlled study. Br. J. Psychiatry 1997; 171: 569-573. (Pubitemid 27527329)